Protecting Health Care Workers During the COVID-19 Outbreak

• Sponsor: Aarogyam UK (Other)
• Overall Status: Completed
• CT.gov ID: NCT04387643
• Collaborator: Samta Ayurveda Prakoshtha, India (Other)
• Enrollment: 52
• Location: 1
• Actual Duration (Months): 1.1
• Patients Per Site Per Month: 49.5

Study Details

Study Description

Brief Summary

Preparing to deal with Covid-19 outbreak in Rajasthan, India, health care workers were given Ayurvedic Kadha (combination of ayurvedic herbal extracts) starting from the end of February 2020. Then, majority of these health care workers were put on front line managing screening, monitoring, quarantine and treating Covid 19 patients. This real-life study aimed to determine the experience of health care workers who had Ayurveda kadha before starting as front-line workers.

Condition or Disease	Intervention/Treatment	Phase
Covid-19	Dietary Supplement: Ayurvedic Kadha

Study Design

• Study Type: Observational
• Actual Enrollment: 52 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: Protecting Health Care Workers During the COVID-19 Outbreak:Qualitative Study of AYUSH Initiative
• Actual Study Start Date: Mar 1, 2020
• Actual Primary Completion Date: Apr 2, 2020
• Actual Study Completion Date: Apr 2, 2020

Outcome Measures

Primary Outcome Measures

1. Physical Health [From baseline to 30-days]

   Self-reported health issues

2. Psychological Health [From baseline to 30-days]

   Self-reported psychological issues

Secondary Outcome Measures

1. Coping with distress [From baseline to 30-days]

   Self-reported coping with high demanding work in Covid-19 duties

2. Self-Help [From baseline to 30-days]

   Self reported self-help measures used

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 60 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Health care workers posted in Covid-19 duties at front line

• Health workers who had Ayurveda herbs combination over for at least 10-days

Exclusion Criteria:

• No willing to consent

• inability to participate

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Samta Ayurveda Prakoshtha	Jaipur	Rajasthan	India

Sponsors and Collaborators

• Aarogyam UK
• Samta Ayurveda Prakoshtha, India

Investigators

• Study Chair: Neha Sharma, British Ayurvedic Medical Council (UK)
• Study Director: Jaydeep Joshi, Aarogyam UK
• Study Director: Parashar Sharma, Samta Ayurveda Prakoshtha, India
• Principal Investigator: Sahil Singhal, Samta Ayurveda Prakoshtha, India

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Aarogyam UK
• ClinicalTrials.gov Identifier: NCT04387643
• Other Study ID Numbers: AU/SA/01
• First Posted: May 14, 2020
• Last Update Posted: May 14, 2020
• Last Verified: May 1, 2020

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: COVID-19

Study Results

No Results Posted as of May 14, 2020